HomeBussinessMedtech firm Vertigenius secures €2.1m in funding for vertigo technology

Medtech firm Vertigenius secures €2.1m in funding for vertigo technology

Date:

Related stories

Young Dublin woman’s rescue of canal cyclist sparks upgrade of pathway

Marianne Gormley (21) was jogging home from work through...

Dublin GAA Juvenile update: Friday 15th November

Fri, 15th November 2024 A Rúnaí, a chara,I attach the...

Dublin’s Liberty Belle is named Local of the Year at Irish Pub Awards

The pub on Francis Street in the Liberties was...

Dublin Airport ask passengers ‘important question’ as flyers left divided

DUBLIN Airport has left passengers divided after asking an "important...
spot_imgspot_img

The company, founded by Dr Dara Meldrum, has developed a wearable head sensor for people suffering from vertigo.

It has also created a clinician portal to allow therapists to monitor symptoms and track exercises carried out by patients.

There is a dedicated app for patients that shows how to correctly complete these exercises.

Vertigo affects around 390 million people each year, the company reported. But a shortage of experts has contributed to delays for many seeking treatment, while the complexity of the exercises can lead to challenges.

Vertigenius said its technology can reduce waiting lists and visits.

It is used by clinics and more than 1,000 patients in Ireland.

The new funding round was led by Irish venture capital firm Atlantic Bridge. It also included investments from Enterprise Ireland and Galway venture capital firm Ascentifi.

Vertigenius plans to use the funds to move into the UK market in the coming months, as well as the US market early next year.

Product development remains a focus for the business, with Vertigenius set to launch a second version of the head sensor in 2025.

The company is also planning to add 10 employees to the existing team following the seed round.

“This investment is a testament to the transformative potential of our products in revolutionising the treatment of vertigo,” Vertigenius chief executive Mark Barry said. “Worldwide, patients who have been diagnosed with vertigo can face months-long waiting lists or an inability to get access to treatment at all.”

Dr Meldrum said the business’ mission is to deliver faster care through technology. “Exercise programmes can be complicated for those in the midst of vertigo episodes, and our patients respond very well to the real-time guidance from our solution,” she said.

Atlantic Bridge investment director Conor O’Sullivan said: “The company’s innovative approach, based on technology developed by Dr Dara Meldrum at Trinity College Dublin, combined with their experienced team led by Mark Barry, and strong market potential, positions the company for significant success.”

Atlantic Bridge has €1.3bn of assets under management across a platform of eight funds. It invests in deep tech companies from seed to growth stage in Ireland, the UK, Europe and the US.

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Latest stories

spot_img